Estimating the Adherence Rate of a Monthly Bubble Package Among Patients Prescribed Adjuvant Endocrine Therapy in Breast Cancer Survivors
Breast Cancer
Conditions: official terms
Breast Neoplasms
Conditions: Keywords
Breast cancer, Anti-estrogen therapy
Study Type
Study Phase
Study Design
Observational Model: Cohort, Time Perspective: Prospective
Name: Bubble packaging of subjects prescription
Type: Other
Overall Status
This study aims to establish the feasibility of using a monthly bubble package to improve compliance rates among women prescribed adjuvant endocrine therapy.
Detailed Description
This study uses Bubble packaging to provide a cost effective way to improve compliance and help direct further interventions to ensure adherence in women on anti-estrogen therapy for breast cancer.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Female
Criteria: Inclusion Criteria:

- 18 years of age or older

- Estrogen receptor positive (> 1% estrogen expression) by immunohistochemistry

- Invasive breast cancer (stage I, II, III) or DCIS considered for adjuvant endocrine therapy

Exclusion Criteria:

- Patients with metastatic disease (stage IV)

- Patients less than 18 years of age

- Prisoners

- Patients are unable to fill prescriptions at the BCC pharmacy due to insurance limitations or personal preference
James Graham Brown Cancer Center-University of Louisville
Louisville, Kentucky, United States
Status: Recruiting
Contact: Elizabeth C Riley, MD - 502-562-3429
Start Date
July 2012
Completion Date
July 2016
James Graham Brown Cancer Center
James Graham Brown Cancer Center
Record processing date processed this data on July 28, 2015 page